Approval based on a comprehensive submission package including efficacy and safety data approximately six months after second dose Spikevax has received approval by regulators in more than 70 countries, including Canada, Japan, the European…Original Article
You may also like
FDA Approves Orlynvah (sulopenem etzadroxil and...
U.S. FDA Approves Pfizer’s RSV Vaccine Abrysvo for...
Alvotech and Teva Announce U.S. FDA Approval of...
FDA Approves Vyloy (zolbetuximab-clzb) for the...
Botox Cosmetic (onabotulinumtoxinA) Receives FDA...
FDA Approves Vyalev (foscarbidopa and foslevodopa) for...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.